Swarm chondrosarcoma: a continued resource for chondroblastic-like extracellular matrix and chondrosarcoma biology research

References

• Choi HU, Meyer K, Swarm R. Mucopolysaccharide and protein-polysaccharide of a transplantable rat chondrosarcoma. Proc Natl Acad Sci USA 1971;68:877–9. Epub 1971/05/01
   PubMed Web of Science ®Google Scholar
• Maibenco HC, Krehbiel RH, Nelson D. Transplantable osteogenic tumor in the rat. Cancer Res 1967;27:362–6
   PubMed Web of Science ®Google Scholar
• Salomon DS, Paglia LM, Verbruggen L. Hormone-dependent growth of a rat chondrosarcoma in vivo. Cancer Res 1979;39:4387–95
   PubMed Web of Science ®Google Scholar
• Kenan S, Steiner GC. Experimental transplantation of the Swarm rat chondrosarcoma into bone: radiological and pathological studies. J Orthop Res 1991;9:445–51
   PubMed Web of Science ®Google Scholar
• Kimura JH, Hardingham TE, Hascall VC, Solursh M. Biosynthesis of proteoglycans and their assembly into aggregates in cultures of chondrocytes from the Swarm rat chondrosarcoma. J Biol Chem 1979;254:2600–9
   PubMed Web of Science ®Google Scholar
• King KB, Kimura JH. The establishment and characterization of an immortal cell line with a stable chondrocytic phenotype. J Cell Biochem 2003;89:992–1004
   PubMed Web of Science ®Google Scholar
• Hauselmann HJ, Masuda K, Hunziker EB, Neidhart M, Mok SS, Michel BA, Thonar EJ. Adult human chondrocytes cultured in alginate form a matrix similar to native human articular cartilage. Am J Physiol 1996;271:C742–52
   PubMed Web of Science ®Google Scholar
• Kimura JH, Thonar EJ, Hascall VC, Reiner A, Poole AR. Identification of core protein, an intermediate in proteoglycan biosynthesis in cultured chondrocytes from the Swarm rat chondrosarcoma. J Biol Chem 1981;256:7890–7
   PubMed Web of Science ®Google Scholar
• Warner LR, Brown RJ, Yingst SM, Oxford JT. Isoform-specific heparan sulfate binding within the amino-terminal noncollagenous domain of collagen alpha1(XI). J Biol Chem 2006;281:39507–16
   PubMed Web of Science ®Google Scholar
• Smith BD, Martin GR, Miller EJ, Dorfman A, Swarm R. Nature of the collagen synthesized by a transplanted chondrosarcoma. Arch Biochem Biophys 1975;166:181–6
   PubMed Web of Science ®Google Scholar
• Saito S, Zeck B, Inerot S, Kuettner KE, Kimura JH. A long term culture of cells from Swarm rat chondrosarcoma in suspension after alginate preculture. Keio J Med 1988;37:282–98
   PubMedGoogle Scholar
• Fernandes RJ, Schmid TM, Harkey MA, Eyre DR. Incomplete processing of type II procollagen by a rat chondrosarcoma cell line. Eur J Biochem 1997;247:620–4
   PubMedGoogle Scholar
• Fernandes RJ, Schmid TM, Eyre DR. Assembly of collagen types II, IX and XI into nascent hetero-fibrils by a rat chondrocyte cell line. Eur J Biochem 2003;270:3243–50
   PubMedGoogle Scholar
• Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D, Basilico C. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 1999;13:1361–6
   PubMed Web of Science ®Google Scholar
• Krejci P, Salazar L, Kashiwada TA, Chlebova K, Salasova A, Thompson LM, Bryja V, Kozubik A, Wilcox WR. Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage. PloS One 2008;3:e3961
   PubMed Web of Science ®Google Scholar
• Stevens JW, Patil SR, Jordan DK, Kimura JH, Morcuende JA. Cytogenetics of swarm rat chondrosarcoma. Iowa Orthop J 2005;25:135–40
   PubMedGoogle Scholar
• Grimaud E, Damiens C, Rousselle AV, Passuti N, Heymann D, Gouin F. Bone remodelling and tumour grade modifications induced by interactions between bone and swarm rat chondrosarcoma. Histol Histopathol 2002;17:1103–11
   PubMed Web of Science ®Google Scholar
• Hamm CA, Stevens JW, Xie H, Vanin EF, Morcuende JA, Abdulkawy H, Seftor EA, Sredni ST, Bischof JM, Wang D, Malchenko S, Bonaldo Mde F, Casavant TL, Hendrix MJ, Soares MB. Microenvironment alters epigenetic and gene expression profiles in Swarm rat chondrosarcoma tumors. BMC Cancer 2010;10:471
   PubMed Web of Science ®Google Scholar
• Czitrom AA, Pritzker KP, Langer F, Gross AE, Luk SC. Virus-induced osteosarcoma in rats. J Bone Joint Surg Am 1976;58:303–8
   PubMed Web of Science ®Google Scholar
• Enneking WF, Flynn L. Effects of VX-2 carcinoma implanted in bone in rabbits. Cancer Res 1968;28:1007–13
   PubMed Web of Science ®Google Scholar
• Friedlaender GE, Mitchell MS. A virally induced osteosarcoma in rats. A model for immunological studies of human osteosarcoma. J Bone Joint Surg Am 1976;58:295–302
   PubMed Web of Science ®Google Scholar
• Aigner T, Muller S, Neureiter D, Illstrup DM, Kirchner T, Bjornsson J. Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas. Cancer 2002;94:2273–81
   PubMed Web of Science ®Google Scholar
• Soderstrom M, Ekfors T, Bohling T, Aho A, Aro HT, Vuorio E. Cysteine proteinases in chondrosarcomas. Matrix Biol 2001;19:717–25
   PubMed Web of Science ®Google Scholar
• Soderstrom M, Aro HT, Ahonen M, Johansson N, Aho A, Ekfors T, Bohling T, Kahari VM, Vuorio E. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. APMIS 2001;109:305–15
   PubMed Web of Science ®Google Scholar
• Aigner T. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton – biochemistry and cell biology of chondrosarcoma and its variants. Virchows Arch 2002;441:219–30
   PubMed Web of Science ®Google Scholar
• O'Neal LW, Ackerman LV. Chondrosarcoma of bone. Cancer 1952;5:551–77
   PubMed Web of Science ®Google Scholar
• Rosenthal DI, Schiller AL, Mankin HJ. Chondrosarcoma: correlation of radiological and histological grade. Radiology 1984;150:21–6
   PubMed Web of Science ®Google Scholar
• Laplantine E, Rossi F, Sahni M, Basilico C, Cobrinik D. FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest. J Cell Biol 2002;158:741–50
   PubMed Web of Science ®Google Scholar
• Cha HJ, Jeong MJ, Kleinman HK. Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 2003;95:1674–80
   PubMed Web of Science ®Google Scholar
• Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T, Takigawa M. CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem 2001;268:6058–65
   PubMedGoogle Scholar
• Masi L, Malentacchi C, Campanacci D, Franchi A. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. Virchows Arch 2002;440:491–7
   PubMed Web of Science ®Google Scholar
• Fransson LA, Belting M, Cheng F, Jonsson M, Mani K, Sandgren S. Novel aspects of glypican glycobiology. Cell Mol Life Sci 2004;61:1016–24
   PubMed Web of Science ®Google Scholar
• Haupt LM, Murali S, Mun FK, Teplyuk N, Mei LF, Stein GS, van Wijnen AJ, Nurcombe V, Cool SM. The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 cells toward osteogenesis. J Cell Physiol 2009;220:780–91
   PubMed Web of Science ®Google Scholar
• Tan TW, Yang WH, Lin YT, Hsu SF, Li TM, Kao ST, Chen WC, Fong YC, Tang CH. Cyr61 increases migration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells. Carcinogenesis 2009;30:258–68
   PubMed Web of Science ®Google Scholar
• Papachristou DJ, Papachristou GI, Papaefthimiou OA, Agnantis NJ, Basdra EK, Papavassiliou AG. The MAPK-AP-1/-Runx2 signalling axes are implicated in chondrosarcoma pathobiology either independently or via up-regulation of VEGF. Histopathology 2005;47:565–74
   PubMed Web of Science ®Google Scholar
• Chen TL, Stevens JW, Cole WG, Hecht JT, Vertel BM. Cell-type specific trafficking of expressed mutant COMP in a cell culture model for PSACH. Matrix Biol 2004;23:433–44
   PubMed Web of Science ®Google Scholar
• Posey KL, Liu P, Wang HR, Veerisetty AC, Alcorn JL, Hecht JT. RNAi reduces expression and intracellular retention of mutant cartilage oligomeric matrix protein. PloS One 2010;5:e10302
   PubMed Web of Science ®Google Scholar
• Zang J, Plaas AHK, Kimura JH. A clonal cell line derived for the Swarm rat chondrosarcoma is defective in expression on the sulfate transporter gene for diastrophic dysplasia. Trans Orthop Res 1999;24:398
   Google Scholar
• Solute carrier family 26 (sulfate transporter), member 2, SLC26A2. Availabale at: http://www.omin.org/entry/606718
   Google Scholar
• Esko JD, Rostand KS, Weinke JL. Tumor formation dependent on proteoglycan biosynthesis. Science 1988;241:1092–6
   PubMed Web of Science ®Google Scholar
• Fernandes RJ, Hirohata S, Engle JM, Colige A, Cohn DH, Eyre DR, Apte SS. Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J Biol Chem 2001;276:31502–9
   PubMed Web of Science ®Google Scholar
• Ozaki T, Lindner N, Hillmann A, Rodl R, Blasius S, Winkelmann W. Influence of intralesional surgery on treatment outcome of chondrosarcoma. Cancer 1996;77:1292–7
   PubMed Web of Science ®Google Scholar
• Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms. Cancer Genet Cytogenet 2003;143:1–31
   PubMed Web of Science ®Google Scholar
• Hamm CA, Xie H, Costa FF, Vanin EF, Seftor EA, Sredni ST, Bischof J, Wang D, Bonaldo MF, Hendrix MJ, Soares MB. Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2′-deoxycytidine results in increased tumorigenicity. PloS One 2009;4:e8340:1--13
   Google Scholar
• Peyrode C, Weber V, David E, Vidal A, Auzeloux P, Communal Y, Dauplat MM, Besse S, Gouin F, Heymann D, Chezal JM, Redini F, Miot-Noirault E. Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies. Invest New Drugs 2012;30:1782–90
   PubMed Web of Science ®Google Scholar
• Schonthal AH. Pharmacological targeting of endoplasmic reticulum stress signaling in cancer. Biochem Pharmacol 2013;85:653–66
   PubMed Web of Science ®Google Scholar
• Meyers CD, Tannock LR, Wight TN, Chait A. Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDL. J Lipid Res 2003;44:2152–60
   PubMed Web of Science ®Google Scholar
• Oegema TR Jr, Parzych SM. Effect of the retinoic acid analog Ro 11-1430 on proteoglycans of swarm rat chondrosarcoma. J Natl Cancer Inst 1981;67:99–106
   PubMed Web of Science ®Google Scholar
• Lyon M, Gallagher JT. Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion. Matrix Biol 1998;17:485–93
   PubMed Web of Science ®Google Scholar
• Iglesias BV, Centeno G, Pascuccelli H, Ward F, Peters MG, Filmus J, Puricelli L, de Kier Joffe EB. Expression pattern of glypican-3 (GPC3) during human embryonic and fetal development. Histol Histopathol 2008;23:1333–40
   PubMed Web of Science ®Google Scholar
• Ornitz DM. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev 2005;16:205–13
   PubMed Web of Science ®Google Scholar
• Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, Filmus J. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003;125:89–97
   PubMed Web of Science ®Google Scholar
• Hippo Y, Watanabe K, Watanabe A, Midorikawa Y, Yamamoto S, Ihara S, Tokita S, Iwanari H, Ito Y, Nakano K, Nezu J, Tsunoda H, Yoshino T, Ohizumi I, Tsuchiya M, Ohnishi S, Makuuchi M, Hamakubo T, Kodama T, Aburatani H. Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res 2004;64:2418–23
   PubMed Web of Science ®Google Scholar
• Feng M, Gao W, Wang R, Chen W, Man YG, Figg WD, Wang XW, Dimitrov DS, Ho M. Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma. Proc Natl Acad Sci USA 2013;110:E1083–91
   PubMed Web of Science ®Google Scholar
• Belting M, Borsig L, Fuster MM, Brown JR, Persson L, Fransson LA, Esko JD. Tumor attenuation by combined heparan sulfate and polyamine depletion. Proc Natl Acad Sci USA 2002;99:371–6
   PubMed Web of Science ®Google Scholar
• Fernandez IS, Cuevas P, Angulo J, Lopez-Navajas P, Canales-Mayordomo A, Gonzalez-Corrochano R, Lozano RM, Valverde S, Jimenez-Barbero J, Romero A, Gimenez-Gallego G. Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors. J Biol Chem 2010;285:11714–29
   PubMed Web of Science ®Google Scholar
• Bovee JV, Hogendoorn PC, Wunder JS, Alman BA. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nat Rev Cancer 2010;10:481–8
   PubMed Web of Science ®Google Scholar